Victory Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Victory Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-60,406	Closed	-$1.13M	–	2849
2021 Q4	$1.13M	Buy	60,406 +3,375	+6%	+$90.1K	﹤0.01%	1787
2021 Q3	$1.87M	Sell	57,031 -4,192	-7%	-$156K	﹤0.01%	1621
2021 Q2	$2.61M	Sell	61,223 -4,768	-7%	-$186K	﹤0.01%	1558
2021 Q1	$2.53M	Buy	+65,991	New	+$2.81M	﹤0.01%	1579
2020 Q4	–	Sell	-13,423	Closed	-$528K	–	2596
2020 Q3	$528K	Sell	13,423 -8,897	-40%	-$287K	﹤0.01%	1935
2020 Q2	$704K	Sell	22,320 -16,148	-42%	-$603K	﹤0.01%	1872
2020 Q1	$1.35M	Buy	38,468 +22,307	+138%	+$940K	﹤0.01%	1746
2019 Q4	$785K	Buy	16,161 +6,458	+67%	+$294K	﹤0.01%	1822
2019 Q3	$461K	Buy	+9,703	New	+$456K	﹤0.01%	1922
2016 Q1	–	Sell	-92,775	Closed	-$1.4M	–	1765
2015 Q4	$1.4M	Sell	92,775 -251,525	-73%	-$3.73M	0.01%	705
2015 Q3	$5.45M	Buy	344,300 +1,904	+0.6%	+$48K	0.02%	543
2015 Q2	$9.06M	Buy	342,396 +255,526	+294%	+$8.25M	0.03%	506
2015 Q1	$3.39M	Buy	+86,870	New	+$2.99M	0.01%	575

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Victory Capital Management's CSII Position: Q1 2022 in Review

Victory Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2022, closing a stake of 60,406 shares — an estimated $1.13M sold.

Victory Capital Management first reported a position in CSII in Q1 2015 and held it in 13 quarters. The position peaked at $9.06M in Q2 2015. 173 funds tracked by Wall St. Rank hold CSII as of Q1 2022.

Victory Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2022 after selling out during the quarter.
Victory Capital Management sold 60,406 Cardiovascular Systems, Inc. shares in Q1 2022, an estimated $1.13M.
Victory Capital Management first reported a position in Cardiovascular Systems, Inc. in Q1 2015 and held it in 13 quarters.
Victory Capital Management's Cardiovascular Systems, Inc. position peaked at $9.06M in Q2 2015.
173 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.